Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 14
2023 106
2024 100
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Tourette syndrome research highlights from 2022.
Hartmann A, Andrén P, Atkinson-Clément C, Czernecki V, Delorme C, Monique Debes NM, Müller-Vahl K, Paschou P, Szejko N, Topaloudi A, Ueda K, Black KJ. Hartmann A, et al. F1000Res. 2023 Oct 23;12:826. doi: 10.12688/f1000research.135702.1. eCollection 2023. F1000Res. 2023. PMID: 37691732 Free PMC article. Review.
This is the ninth yearly article in the Tourette Syndrome Research Highlights series, summarizing selected research reports from 2022 relevant to Tourette syndrome. ...
This is the ninth yearly article in the Tourette Syndrome Research Highlights series, summarizing selected research reports fr …
Tourette Syndrome and Tic Disorders.
Trau SP, Singer HS. Trau SP, et al. Pediatr Rev. 2024 Feb 1;45(2):85-95. doi: 10.1542/pir.2023-006014. Pediatr Rev. 2024. PMID: 38296781 No abstract available.
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.
Mosley PE, Webb L, Suraev A, Hingston L, Turnbull T, Foster K, Ballard E, Gomes L, Mohan A, Sachdev PS, Kevin R, Gordon R, Benson M, McGregor IS. Mosley PE, et al. NEJM Evid. 2023 Sep;2(9):EVIDoa2300012. doi: 10.1056/EVIDoa2300012. Epub 2023 Jun 7. NEJM Evid. 2023. PMID: 38320199 Clinical Trial.
BACKGROUND: Tourette syndrome is characterized by chronic motor and vocal tics. There is preliminary evidence of benefit from cannabis products containing delta9-tetrahydrocannabinol (THC) and that coadministration of cannabidiol (CBD) improves the side-effect profi …
BACKGROUND: Tourette syndrome is characterized by chronic motor and vocal tics. There is preliminary evidence of benefit from …
Tics emergencies and malignant tourette syndrome: Assessment and management.
Baizabal-Carvallo JF, Cavanna AE, Jankovic J. Baizabal-Carvallo JF, et al. Neurosci Biobehav Rev. 2024 Apr;159:105609. doi: 10.1016/j.neubiorev.2024.105609. Epub 2024 Mar 4. Neurosci Biobehav Rev. 2024. PMID: 38447821 Review.
Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the presence of tics, frequently accompanied by a variety of neuropsychiatric comorbidities. ...
Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the presence of tics, frequently accompanied
Neurosurgical lesioning for Tourette syndrome.
Tuleasca C, Régis J, Martinez-Alvarez R, Levivier M, Hariz M. Tuleasca C, et al. Lancet Neurol. 2023 Apr;22(4):292. doi: 10.1016/S1474-4422(23)00078-9. Lancet Neurol. 2023. PMID: 36931796 No abstract available.
Tourette syndrome research highlights from 2023.
Hartmann A, Andrén P, Atkinson-Clement C, Czernecki V, Delorme C, Mol Debes N, Morand-Beaulieu S, Müller-Vahl K, Paschou P, Szejko N, Topaloudi A, Black KJ. Hartmann A, et al. F1000Res. 2024 Aug 9;13:677. doi: 10.12688/f1000research.150931.2. eCollection 2024. F1000Res. 2024. PMID: 39296887 Free PMC article. Review.
In this, the tenth annual update for the F1000Research Tics collection, we summarize research reports from 2023 on Gilles de la Tourette syndrome and other tic disorders. The authors welcome article suggestions and thoughtful feedback from readers....
In this, the tenth annual update for the F1000Research Tics collection, we summarize research reports from 2023 on Gilles de la Tourette
Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD.
Wang S, Wang B, Drury V, Drake S, Sun N, Alkhairo H, Arbelaez J, Duhn C; Tourette International Collaborative Genetics (TIC Genetics); Bal VH, Langley K, Martin J, Hoekstra PJ, Dietrich A, Xing J, Heiman GA, Tischfield JA, Fernandez TV, Owen MJ, O'Donovan MC, Thapar A, State MW, Willsey AJ. Wang S, et al. Nat Commun. 2023 Dec 6;14(1):8077. doi: 10.1038/s41467-023-43776-0. Nat Commun. 2023. PMID: 38057346 Free PMC article.
Autism spectrum disorder (ASD), Tourette syndrome (TS), and attention-deficit/hyperactivity disorder (ADHD) display strong male sex bias, due to a combination of genetic and biological factors, as well as selective ascertainment. ...
Autism spectrum disorder (ASD), Tourette syndrome (TS), and attention-deficit/hyperactivity disorder (ADHD) display strong mal …
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Müller-Vahl KR, et al. Psychiatry Res. 2023 May;323:115135. doi: 10.1016/j.psychres.2023.115135. Epub 2023 Feb 28. Psychiatry Res. 2023. PMID: 36878177 Free article. Clinical Trial.
Preliminary data suggest that cannabis-based medicines might be a promising new treatment for patients with Tourette syndrome (TS)/chronic tic disorders (CTD) resulting in an improvement of tics, comorbidities, and quality of life. ...
Preliminary data suggest that cannabis-based medicines might be a promising new treatment for patients with Tourette syndrome
182 results